MX369628B - Genes nano46 y metodos para predecir el resultado del cancer de mama. - Google Patents

Genes nano46 y metodos para predecir el resultado del cancer de mama.

Info

Publication number
MX369628B
MX369628B MX2014014275A MX2014014275A MX369628B MX 369628 B MX369628 B MX 369628B MX 2014014275 A MX2014014275 A MX 2014014275A MX 2014014275 A MX2014014275 A MX 2014014275A MX 369628 B MX369628 B MX 369628B
Authority
MX
Mexico
Prior art keywords
methods
breast cancer
subject
gene expression
evaluating
Prior art date
Application number
MX2014014275A
Other languages
English (en)
Other versions
MX2014014275A (es
Inventor
Sean M Ferree
James J Storhoff
Joel S Parker
Charles M Perou
Matthew J Ellis
Philip S Bernard
Torsten O Nielsen
Original Assignee
Nanostring Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanostring Technologies Inc filed Critical Nanostring Technologies Inc
Publication of MX2014014275A publication Critical patent/MX2014014275A/es
Publication of MX369628B publication Critical patent/MX369628B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La presente invención se refiere a un método para determinar el riesgo de recidiva de cáncer de mama en un sujeto caracterizado porque comprende: determinar el tamaño de un tumor de cáncer de mama del sujeto: determinar un valor de correlación del tumor de cáncer de mama del sujeto para cada uno de por lo menos cuatro subtipos intrínsecos que incluyen tipo Basal, Luminal A, Luminal B, o enriquecido con HER-2, al medir la expresión de por lo menos cuarenta de los genes en la lista de genes intrínsecos en el tumor de cáncer de mama del sujeto.
MX2014014275A 2012-05-22 2013-05-22 Genes nano46 y metodos para predecir el resultado del cancer de mama. MX369628B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261650209P 2012-05-22 2012-05-22
US201361753673P 2013-01-17 2013-01-17
PCT/US2013/042157 WO2013177245A2 (en) 2012-05-22 2013-05-22 Nano46 genes and methods to predict breast cancer outcome

Publications (2)

Publication Number Publication Date
MX2014014275A MX2014014275A (es) 2015-07-06
MX369628B true MX369628B (es) 2019-11-14

Family

ID=49624503

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014014275A MX369628B (es) 2012-05-22 2013-05-22 Genes nano46 y metodos para predecir el resultado del cancer de mama.

Country Status (12)

Country Link
US (3) US20130337444A1 (es)
EP (1) EP2852689B1 (es)
JP (1) JP6325530B2 (es)
CN (2) CN104704128A (es)
AU (1) AU2013266419B2 (es)
BR (1) BR112014029300A2 (es)
CA (1) CA2874492C (es)
ES (1) ES2763931T3 (es)
IL (1) IL235795B (es)
IN (1) IN2014MN02418A (es)
MX (1) MX369628B (es)
WO (1) WO2013177245A2 (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2457534T3 (es) 2008-05-30 2014-04-28 The University Of North Carolina At Chapel Hill Perfiles de expresión génica para predecir desenlaces en cáncer de mama
AU2012229123B2 (en) 2011-03-15 2017-02-02 British Columbia Cancer Agency Branch Methods of treating breast cancer with anthracycline therapy
GB201106254D0 (en) 2011-04-13 2011-05-25 Frisen Jonas Method and product
EP2785873A4 (en) 2011-11-30 2015-11-11 Univ North Carolina METHOD FOR THE TREATMENT OF BREAST CANCER WITH TAXAN THERAPY
EP2909337B1 (en) 2012-10-17 2019-01-09 Spatial Transcriptomics AB Methods and product for optimising localised or spatial detection of gene expression in a tissue sample
EP2997163A4 (en) * 2013-05-13 2017-02-22 Nanostring Technologies, Inc Methods to predict risk of recurrence in node-positive early breast cancer
LT3013983T (lt) 2013-06-25 2023-05-10 Prognosys Biosciences, Inc. Erdviniai koduoti biologiniai tyrimai, naudojant mikrofluidinį įrenginį
US20150072021A1 (en) 2013-09-09 2015-03-12 British Columbia Cancer Agency Branch Methods and Kits for Predicting Outcome and Methods and Kits for Treating Breast Cancer with Radiation Therapy
KR102105236B1 (ko) 2014-11-21 2020-04-28 나노스트링 테크놀로지스, 인크. 무효소 및 무증폭 시퀀싱
CA2968519C (en) * 2014-11-24 2024-01-09 Nanostring Technologies, Inc. Methods and apparatuses for gene purification and imaging
AU2015359479A1 (en) * 2014-12-09 2017-06-15 King's College London Breast cancer treatment with taxane therapy
EP4321627A3 (en) 2015-04-10 2024-04-17 10x Genomics Sweden AB Spatially distinguished, multiplex nucleic acid analysis of biological specimens
CN107850599B (zh) * 2015-07-23 2021-02-09 新加坡国立大学 Wbp2与her2作为共预后因子对患者分层以进行治疗
SG11201809913PA (en) 2016-05-16 2018-12-28 Nanostring Technologies Inc Methods for detecting target nucleic acids in a sample
WO2017222453A1 (en) 2016-06-21 2017-12-28 Hauling Thomas Nucleic acid sequencing
WO2018074865A2 (ko) * 2016-10-21 2018-04-26 서울대학교병원 유방암 예후 예측용 조성물 및 방법
CN110225980B (zh) 2016-11-21 2023-01-06 纳米线科技公司 化学组合物及其使用方法
KR101950717B1 (ko) * 2016-11-23 2019-02-21 주식회사 젠큐릭스 유방암 환자의 화학치료 유용성 예측 방법
WO2018144782A1 (en) * 2017-02-01 2018-08-09 The Translational Genomics Research Institute Methods of detecting somatic and germline variants in impure tumors
CA3078158A1 (en) 2017-10-06 2019-04-11 Cartana Ab Rna templated ligation
KR102071491B1 (ko) * 2017-11-10 2020-01-30 주식회사 디시젠 차세대 염기서열분석을 이용한 기계학습 기반 유방암 예후 예측 방법 및 예측 시스템
CN112703255A (zh) 2018-05-14 2021-04-23 纳米线科技公司 化学组合物及其使用方法
US20210371936A1 (en) * 2018-11-05 2021-12-02 Biontech Diagnostics Gmbh Predictive methods in breast cancer
CN113906147B (zh) 2019-05-31 2024-09-13 10X基因组学有限公司 检测目标核酸分子的方法
JP7352937B2 (ja) * 2019-07-19 2023-09-29 公立大学法人福島県立医科大学 乳癌のサブタイプを鑑別又は分類するための鑑別マーカー遺伝子セット、方法およびキット
EP3945136A1 (en) * 2020-07-28 2022-02-02 Hospital Clínic de Barcelona In vitro method for the prognosis of patients suffering from her2-positive breast cancer
US12060603B2 (en) 2021-01-19 2024-08-13 10X Genomics, Inc. Methods for internally controlled in situ assays using padlock probes
AU2022419002A1 (en) * 2021-12-20 2024-08-01 Fundació De Recerca Clínic Barcelona-Institut D’Investigacions Biomèdiques August Pi I Sunyer Development and validation of an in vitro method for the prognosis of patients suffering from her2-positive breast cancer
CN117965734B (zh) * 2024-02-02 2024-09-24 奥明星程(杭州)生物科技有限公司 一种用于检测硬纤维瘤的基因标志物、试剂盒、检测方法及应用

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5800992A (en) 1989-06-07 1998-09-01 Fodor; Stephen P.A. Method of detecting nucleic acids
US6040138A (en) 1995-09-15 2000-03-21 Affymetrix, Inc. Expression monitoring by hybridization to high density oligonucleotide arrays
AU669489B2 (en) 1991-09-18 1996-06-13 Affymax Technologies N.V. Method of synthesizing diverse collections of oligomers
US5384261A (en) 1991-11-22 1995-01-24 Affymax Technologies N.V. Very large scale immobilized polymer synthesis using mechanically directed flow paths
ATE293011T1 (de) 1991-11-22 2005-04-15 Affymetrix Inc A Delaware Corp Kombinatorische strategien für die polymersynthese
US5856174A (en) 1995-06-29 1999-01-05 Affymetrix, Inc. Integrated nucleic acid diagnostic device
EP0880598A4 (en) 1996-01-23 2005-02-23 Affymetrix Inc RAPID EVALUATION OF NUCLEIC ACID ABUNDANCE DIFFERENCE, WITH A HIGH-DENSITY OLIGONUCLEOTIDE SYSTEM
AU1287799A (en) 1997-10-31 1999-05-24 Affymetrix, Inc. Expression profiles in adult and fetal organs
US6020135A (en) 1998-03-27 2000-02-01 Affymetrix, Inc. P53-regulated genes
US6750015B2 (en) * 2000-06-28 2004-06-15 Kathryn B. Horwitz Progesterone receptor-regulated gene expression and methods related thereto
US20020168639A1 (en) * 2000-09-22 2002-11-14 Muraca Patrick J. Profile array substrates
ES2787475T3 (es) 2003-06-24 2020-10-16 Genomic Health Inc Predicción de probabilidad de recurrencia del cáncer
US20050071087A1 (en) * 2003-09-29 2005-03-31 Anderson Glenda G. Systems and methods for detecting biological features
CA2574447A1 (en) 2004-07-15 2006-01-26 University Of Utah Research Foundation Housekeeping genes and methods for identifying the same
CN101061480A (zh) * 2004-09-22 2007-10-24 三路影像公司 用来分析和优化用于癌症诊断的标记候选物的方法和计算机程序产品
US20090299640A1 (en) 2005-11-23 2009-12-03 University Of Utah Research Foundation Methods and Compositions Involving Intrinsic Genes
CA2640385C (en) 2005-12-23 2014-07-15 Nanostring Technologies, Inc. Nanoreporters and methods of manufacturing and use thereof
CA2635215C (en) 2005-12-23 2016-08-30 Nanostring Technologies, Inc. Compositions comprising oriented, immobilized macromolecules and methods for their preparation
AU2008237018B2 (en) 2007-04-10 2014-04-03 Bruker Spatial Biology, Inc. Methods and computer systems for identifying target-specific sequences for use in nanoreporters
WO2008150512A2 (en) * 2007-06-04 2008-12-11 University Of Louisville Research Foundation, Inc. Methods for identifying an increased likelihood of recurrence of breast cancer
CA2698569A1 (en) * 2007-09-06 2009-09-03 Mark G. Erlander Tumor grading and cancer prognosis
ES2457534T3 (es) * 2008-05-30 2014-04-28 The University Of North Carolina At Chapel Hill Perfiles de expresión génica para predecir desenlaces en cáncer de mama
JP5836803B2 (ja) 2008-08-14 2015-12-24 ナノストリング テクノロジーズ， インコーポレイテッド 安定したナノレポーター
KR101864855B1 (ko) * 2010-03-31 2018-07-13 지피돈 디아그노스틱스 게엠베하 내분비 치료 중 유방암 재발 예측 방법

Also Published As

Publication number Publication date
CN104704128A (zh) 2015-06-10
JP6325530B2 (ja) 2018-05-16
CA2874492A1 (en) 2013-11-28
US20230272476A1 (en) 2023-08-31
IL235795A0 (en) 2015-01-29
EP2852689A4 (en) 2016-05-11
IN2014MN02418A (es) 2015-08-14
CA2874492C (en) 2021-10-19
CN111500718A (zh) 2020-08-07
EP2852689A2 (en) 2015-04-01
IL235795B (en) 2020-02-27
WO2013177245A3 (en) 2015-01-29
BR112014029300A2 (pt) 2017-07-25
MX2014014275A (es) 2015-07-06
ES2763931T3 (es) 2020-06-01
JP2015518724A (ja) 2015-07-06
AU2013266419B2 (en) 2018-09-27
WO2013177245A2 (en) 2013-11-28
US20200332368A1 (en) 2020-10-22
AU2013266419A1 (en) 2014-12-11
US20130337444A1 (en) 2013-12-19
EP2852689B1 (en) 2019-12-11

Similar Documents

Publication Publication Date Title
MX369628B (es) Genes nano46 y metodos para predecir el resultado del cancer de mama.
CY1114993T1 (el) Προφιλ εκφρασης γονιδιου για να προβλεπονται εκβασεις καρκινου μαστου
EA201390762A1 (ru) Новые биомаркеры для предсказания исхода противораковой иммунотерапии
MX2019007814A (es) Algoritmo de perfil de expresion genica y prueba para determinar la prognosis de cancer de prostata.
GB201316222D0 (en) Biomarker panels diagnostic and test kits for ovarian cancer
WO2010051314A3 (en) Genomic classification of non-small cell lung carcinoma based on patterns of gene copy number alterations
NZ621638A (en) Dna methylation in colorectal and breast cancer diagnostic methods
NZ701652A (en) Breast cancer prognosis, prediction of progesterone receptor subtype and|prediction of response to antiprogestin treatment based on gene expression
CY1117838T1 (el) Παραγοντες προβλεψης για θεραπευτικη αγωγη καρκινου
WO2014184679A3 (en) Method for the prognosis and treatment of renal cell carcinoma metastasis
MX2013008252A (es) Firma de pronostico para la recurrencia de cancer colorrectal.
BR112015022977A2 (pt) métodos para predição de risco de metástase em melanoma cutâneo
Montserrat et al. Present and future of personalized medicine in CLL
MX2016012718A (es) Determinación de polimorfismos de un solo nucleótido útil para predecir la respuesta para rasagilina.
WO2016066797A3 (en) Prognostic grouping of ovarian cancer patients
Eapen Relapsed acute lymphoblastic leukemia: Is it crucial to achieve molecular remission prior to transplant?
MX2017004816A (es) Métodos para predecir resultados clínicos en sujetos afectados con colitis ulcerosa.
UA108260U (uk) Спосіб прогнозування розвитку остеопорозу
UA126823U (uk) Спосіб прогнозування розвитку бронхіальної астми у хворих на ожиріння
UA95616U (uk) Спосіб прогнозування зрощення перелому
WO2011133500A3 (en) Detection and analysis of epigenetic and genetic changes in tumor tissue
UA109472U (uk) Спосіб діагностики розвитку остеопорозу
UA108659U (uk) Спосіб діагностики розвитку остеопорозу
UA117583U (uk) Спосіб прогнозування коліешерихіозного ендотоксикозу з урахуванням генетичних чинників
Brennan Quantifying Biomarker Risks and Benefits

Legal Events

Date Code Title Description
FG Grant or registration